— Know what they know.
Not Investment Advice
Also trades as: CVSG.L (LSE) · $vol 4M

CVSGF OTC

CVS Group plc
1W: +0.0% 1M: +0.0% 3M: +0.3% YTD: +2.3% 1Y: +1.8% 3Y: -29.6% 5Y: -50.9%
$16.60
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Care Facilities · Tech Score Sell · Power 51 · $1.1B mcap · 68M float · 0.0005% daily turnover · Short 100% of daily vol

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
Analyst Recommendations
Strong Buy: 0Buy: 2Hold: 0Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$—
Analysts0

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B
Oct 02, 2026
DCF
4
ROE
3
ROA
5
D/E
1
P/E
1
P/B
2
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. CVSGF receives an overall rating of B. Strongest factors: DCF (4/5), ROA (5/5). Areas of concern: D/E (1/5), P/E (1/5), P/B (2/5).
Rating Change History
DateFromTo
2026-10-03 None ADDED
2026-10-03 EXISTED None
2026-09-29 None ADDED
2026-09-27 EXISTED None
2026-09-23 None ADDED
2026-09-23 EXISTED None
2026-09-19 None ADDED
2026-09-19 EXISTED None
2026-09-15 None ADDED
2026-09-13 EXISTED None

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ — Grade B
Profitability
40
Balance Sheet
48
Earnings Quality
59
Growth
53
Value
—
Momentum
80
Safety
—
Cash Flow
64

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
—
—
Piotroski F-Score
6/9
✓ ✓ ✗ ✓ ✗ ✓ ✓ ✗ ✓
Beneish M-Score
-2.49
Unlikely Manipulator
Ohlson O-Score
-6.69
Bankruptcy prob: 0.1%
Low Risk
Credit Rating
BBB+
Score: 63.8/100
Trend: Improving
Earnings Quality
75/100
OCF/NI: 3.88x
Accruals: -17.4%
The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. CVSGF scores 6/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. CVSGF's score of -2.49 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. CVSGF's implied 0.1% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. CVSGF receives an estimated rating of BBB+ (score: 63.8/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). CVSGF's score of 75/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
45.60x
PEG
-6.16x
P/S
1.10x
P/B
2.72x
P/FCF
—
P/OCF
—
EV/EBITDA
—
EV/Revenue
—
EV/EBIT
—
EV/FCF
—
Earnings Yield
—
FCF Yield
—
Shareholder Yield
—
Graham Number
$7.71
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 45.6x earnings, CVSGF is priced for high growth expectations. Graham's intrinsic value formula yields $7.71 per share, 115% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.571
NI / EBT
×
Interest Burden
0.527
EBT / EBIT
×
EBIT Margin
0.089
EBIT / Rev
×
Asset Turnover
2.257
Rev / Assets
×
Equity Multiplier
2.648
Assets / Equity
=
ROE
16.0%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. CVSGF's ROE of 16.0% is driven by Asset Turnover (2.257), indicating efficient use of assets to generate revenue. A tax burden ratio of 0.57 suggests the company retains less than 60% of pre-tax earnings after taxes.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
15.00%
Fair P/E
38.50x
Intrinsic Value
$24.41
Price/Value
—
Margin of Safety
—
Premium
—
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with CVSGF's realized 15.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. CVSGF actually compounded EPS at 50.6% over three years; the model uses 15%, the highest rate it will extrapolate — of 4,457 company-quarters that grew faster than 200%, none sustained it over the following seven years. CVSGF trades at a premium to its adjusted intrinsic value of $24.41, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 38.5x compares to the current market P/E of 45.6x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$16.60
Median 1Y
$16.67
5th Pctile
$7.71
95th Pctile
$36.26
Ann. Volatility
46.6%
25th–75th percentile 5th–95th percentile Median path Historical
All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
ROE 3.7% 4.2% 8.6% 11.4% 8.1% 14.2% 13.7% 19.9% 23.4% 26.5% 30.2% 27.4% 20.1% 15.4% 11.7% 9.2% 16.0% 15.99%
ROA 1.8% 1.8% 3.7% 4.0% 3.4% 5.5% 5.6% 7.6% 9.2% 10.8% 12.8% 11.2% 8.0% 6.2% 4.3% 3.8% 6.0% 6.04%
ROIC 2.9% 3.2% 6.6% 10.6% 7.1% 12.1% 11.9% 14.5% 17.7% 18.2% 20.3% 15.1% 14.5% 12.8% 16.1% 16.5% 17.2% 17.18%
ROCE 3.4% 4.0% 8.2% 7.8% 6.9% 8.2% 7.6% 9.1% 11.9% 13.0% 14.3% 12.5% 9.3% 11.0% 10.7% 17.3% 22.9% 22.90%
Gross Margin 46.2% 42.0% 36.0% 31.6% 37.8% 38.6% 39.1% 37.7% 40.6% 38.9% 39.8% 88.0% 41.9% 43.5% 35.7% 40.6% 40.7% 40.66%
Operating Margin 5.3% 1.7% 5.8% 6.2% 3.6% 9.2% 10.1% 10.3% 6.9% 11.2% 11.4% 9.9% 5.9% 7.7% 12.4% 9.8% 11.9% 11.86%
Net Margin 3.4% 0.4% 3.5% 2.2% 0.0% 4.6% 3.0% 6.4% 2.9% 7.1% 6.7% 9.1% -2.6% 3.3% 2.6% 2.2% 2.7% 2.67%
EBITDA Margin 13.3% 9.9% 13.1% 13.1% 12.9% 12.9% 13.7% 13.5% 15.4% 13.6% 15.2% 22.0% 19.7% 14.7% 18.3% 19.0% 20.9% 20.88%
FCF Margin 6.5% 5.5% 6.9% 7.9% 11.3% 13.7% 11.6% 10.5% 8.9% 6.6% 7.7% 9.0% 6.3% 6.9% 6.9% 6.2% 6.7% 6.72%
OCF Margin 9.2% 8.4% 9.9% 10.9% 14.3% 16.5% 14.7% 13.9% 12.8% 11.5% 13.8% 16.2% 12.9% 12.6% 11.0% 9.6% 10.4% 10.37%
ROE 3Y Avg snapshot only 18.13%
ROE 5Y Avg snapshot only 13.20%
ROA 3Y Avg snapshot only 7.14%
ROIC 3Y Avg snapshot only 9.13%
ROIC Economic snapshot only 17.18%
Cash ROA snapshot only 22.29%
Cash ROIC snapshot only 28.91%
CROIC snapshot only 18.74%
NOPAT Margin snapshot only 6.16%
Pretax Margin snapshot only 4.69%
R&D / Revenue snapshot only 0.00%
SGA / Revenue snapshot only 27.38%
SBC / Revenue snapshot only 0.05%
Valuation
Metric Trend Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
P/E Ratio — — — — — — — — — — — — — — — — — 45.600
P/S Ratio — — — — — — — — — — — — — — — — — 1.100
P/B Ratio — — — — — — — — — — — — — — — — — 2.717
P/FCF — — — — — — — — — — — — — — — — — —
P/OCF — — — — — — — — — — — — — — — — — —
EV/EBITDA — — — — — — — — — — — — — — — — — —
EV/Revenue — — — — — — — — — — — — — — — — — —
EV/EBIT — — — — — — — — — — — — — — — — — —
EV/FCF — — — — — — — — — — — — — — — — — —
Earnings Yield — — — — — — — — — — — — — — — — — —
FCF Yield — — — — — — — — — — — — — — — — — —
Graham Number snapshot only $7.71
Leverage & Solvency
Metric Trend Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
Current Ratio 1.15 1.13 1.03 0.84 0.82 0.92 1.03 1.08 1.26 1.16 1.06 1.15 1.09 1.08 1.10 1.07 1.18 1.176
Quick Ratio 0.92 0.89 0.81 0.61 0.64 0.74 0.83 0.83 1.00 0.85 0.79 0.88 0.82 0.82 0.93 0.81 0.94 0.941
Debt/Equity 0.53 0.83 0.70 0.63 1.09 1.02 0.96 0.90 0.87 0.80 0.77 1.01 1.11 1.13 0.83 0.92 1.10 1.104
Net Debt/Equity 0.44 0.75 0.63 0.59 0.96 0.79 0.78 0.80 0.64 0.68 0.68 0.89 1.04 1.09 0.76 0.88 1.04 1.041
Debt/Assets 0.26 0.34 0.30 0.22 0.39 0.37 0.38 0.38 0.36 0.36 0.35 0.41 0.42 0.42 0.26 0.38 0.42 0.417
Debt/EBITDA 3.73 3.10 1.65 1.05 1.77 1.59 1.48 1.42 1.28 1.20 1.19 1.61 1.54 1.50 0.97 0.94 1.06 1.062
Net Debt/EBITDA 3.07 2.79 1.47 0.98 1.57 1.24 1.21 1.25 0.95 1.02 1.05 1.42 1.45 1.44 0.88 0.90 1.00 1.001
Interest Coverage — — 11.71 4.69 2.32 2.14 1.88 2.50 3.60 4.11 4.40 3.13 2.53 2.40 2.32 3.16 3.72 3.716
Equity Multiplier 2.02 2.42 2.31 2.87 2.79 2.73 2.54 2.40 2.38 2.26 2.23 2.48 2.65 2.66 3.19 2.43 2.65 2.647
Cash Ratio snapshot only 0.146
Debt Service Coverage snapshot only 7.624
Cash to Debt snapshot only 0.057
FCF to Debt snapshot only 0.346
Defensive Interval snapshot only 91.3 days
Efficiency & Turnover
Metric Trend Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
Asset Turnover 0.53 0.97 1.53 1.69 2.13 2.04 2.18 2.05 2.17 2.19 2.20 1.82 1.81 1.86 1.85 2.33 2.26 2.257
Inventory Turnover 6.76 12.86 19.98 25.82 32.82 31.89 32.43 29.21 28.92 28.13 29.47 21.70 19.92 20.00 27.30 32.54 32.37 32.371
Receivables Turnover 9.91 8.01 21.49 18.70 36.20 19.73 30.30 21.39 32.40 23.82 31.04 19.48 32.79 20.76 35.27 25.30 31.38 31.377
Payables Turnover 2.91 3.24 8.05 7.11 14.95 10.69 14.35 11.64 16.27 17.29 17.26 14.79 12.77 15.20 14.23 24.74 12.79 12.788
DSO 37 46 17 20 10 19 12 17 11 15 12 19 11 18 10 14 12 11.6 days
DIO 54 28 18 14 11 11 11 12 13 13 12 17 18 18 13 11 11 11.3 days
DPO 125 112 45 51 24 34 25 31 22 21 21 25 29 24 26 15 29 28.5 days
Cash Conversion Cycle -34 -39 -10 -18 -3 -4 -2 -2 1 7 3 11 1 12 -2 11 -6 -5.6 days
Fixed Asset Turnover snapshot only 7.045
Operating Cycle snapshot only 22.9 days
Cash Velocity snapshot only 89.712
Capital Intensity snapshot only 0.465
Growth (YoY)
Metric Trend Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
Revenue — — — — 3.9% 1.4% 62.8% 23.3% 27.6% 26.0% 23.9% 6.3% 2.9% 2.3% 21.4% 53.3% 49.6% 49.62%
Net Income — — — — 1.3% 2.6% 73.6% 95.2% 2.4% 1.3% 1.8% 75.3% 6.9% -30.3% -51.6% -60.0% -8.8% -8.85%
EPS — — — — 1.2% 2.6% 71.1% 92.9% 2.4% 1.3% 1.8% 75.2% 6.5% -30.3% -51.8% -60.0% -5.4% -5.43%
FCF — — — — 7.5% 5.0% 1.7% 64.8% 0.7% -38.9% -17.5% -8.8% -27.4% 6.1% 8.2% 5.0% 60.4% 60.38%
EBITDA — — — — 3.6% 1.8% 77.6% 32.1% 44.1% 36.2% 36.0% 27.1% 26.5% 25.9% 52.8% 73.9% 59.9% 59.92%
Op. Income — — — — 3.1% 3.5% 1.9% 1.2% 1.6% 91.6% 64.9% 22.3% 7.0% -9.9% 14.6% 46.8% 69.5% 69.48%
OCF Growth snapshot only 20.62%
Asset Growth snapshot only 10.47%
Equity Growth snapshot only 10.60%
Debt Growth snapshot only 10.49%
Shares Change snapshot only -3.61%
Dividend Growth snapshot only 4.18%
Growth (CAGR)
Metric Trend Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
Revenue 3Y — — — — — — — — — — — — 86.3% 46.3% 34.8% 26.2% 25.2% 25.24%
Revenue 5Y — — — — — — — — — — — — — — — — — —
EPS 3Y — — — — — — — — — — — — 99.6% 78.6% 31.9% 10.6% 50.6% 50.59%
EPS 5Y — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — 1.0% 79.5% 32.7% 11.1% 49.2% 49.20%
Net Income 5Y — — — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — 1.0% 67.7% 54.5% 42.9% 42.9% 42.86%
EBITDA 5Y — — — — — — — — — — — — — — — — — —
Gross Profit 3Y — — — — — — — — — — — — 87.7% 50.9% 39.0% 27.6% 28.4% 28.35%
Gross Profit 5Y — — — — — — — — — — — — — — — — — —
Op. Income 3Y — — — — — — — — — — — — 1.3% 98.5% 75.8% 58.3% 68.4% 68.36%
Op. Income 5Y — — — — — — — — — — — — — — — — — —
FCF 3Y — — — — — — — — — — — — 84.1% 57.6% 34.7% 16.4% 5.5% 5.46%
FCF 5Y — — — — — — — — — — — — — — — — — —
OCF 3Y — — — — — — — — — — — — 1.1% 67.6% 39.5% 20.8% 12.6% 12.60%
OCF 5Y — — — — — — — — — — — — — — — — — —
Assets 3Y — — — — — — — — — — — — 29.3% 22.8% 36.3% 14.8% 18.0% 17.97%
Assets 5Y — — — — — — — — — — — — — — — — — —
Equity 3Y — — — — — — — — — — — — 18.2% 18.9% 22.5% 21.3% 20.0% 20.02%
Book Value 3Y — — — — — — — — — — — — 16.6% 18.3% 21.8% 20.8% 21.1% 21.13%
Dividend 3Y — — — — — — — — — — — — 34.8% 8.5% 8.4% 7.7% 1.1% 1.07%
Growth Quality
Metric Trend Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
Revenue Stability — — — — — — — — 0.93 0.95 0.98 0.92 0.81 0.84 0.99 0.85 0.86 0.857
Earnings Stability — — — — — — — — 0.89 0.97 0.89 0.98 0.90 0.63 0.30 0.10 0.77 0.767
Margin Stability — — — — — — — — 0.88 0.90 0.95 0.88 0.88 0.87 0.92 0.90 0.89 0.887
Rev. Growth Consistency 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.000
FCF Positive Streak 0 0 0 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence — — — — — — — — 0.50 0.50 0.50 0.50 0.97 0.88 0.50 0.50 0.96 0.965
Earnings Smoothness — — — — 0.22 0.00 0.46 0.35 0.00 0.21 0.06 0.45 0.93 0.64 0.30 0.14 0.91 0.907
ROE Trend — — — — — — — — 0.15 0.15 0.16 0.10 0.04 -0.04 -0.09 -0.12 -0.04 -0.044
Gross Margin Trend — — — — — — — — -0.02 -0.01 0.00 0.09 0.09 0.11 0.07 -0.03 -0.04 -0.037
FCF Margin Trend — — — — — — — — 0.00 -0.03 -0.02 -0.00 -0.04 -0.03 -0.03 -0.04 -0.01 -0.009
Sustainable Growth Rate 3.6% 1.9% 6.4% 6.9% 3.6% 11.8% 11.5% 17.4% 21.0% 21.9% 25.9% 23.0% 15.2% 10.4% 7.3% 4.5% 11.7% 11.69%
Internal Growth Rate 1.8% 0.8% 2.8% 2.5% 1.5% 4.8% 5.0% 7.2% 9.0% 9.8% 12.3% 10.4% 6.4% 4.4% 2.7% 1.9% 4.6% 4.62%
Cash Flow Quality
Metric Trend Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
OCF/Net Income 2.69 4.64 4.07 4.61 9.02 6.16 5.67 3.71 3.02 2.35 2.37 2.63 2.93 3.77 4.73 5.94 3.88 3.875
FCF/OCF 0.71 0.65 0.70 0.72 0.79 0.83 0.79 0.76 0.70 0.57 0.56 0.56 0.49 0.54 0.63 0.65 0.65 0.648
FCF/Net Income snapshot only 2.512
OCF/EBITDA snapshot only 0.568
CapEx/Revenue 2.7% 2.9% 3.0% 3.0% 3.0% 2.9% 3.1% 3.3% 3.9% 4.9% 6.0% 7.2% 6.6% 5.8% 4.1% 3.4% 3.6% 3.65%
CapEx/Depreciation snapshot only 0.390
Accruals Ratio -0.03 -0.06 -0.11 -0.14 -0.27 -0.28 -0.26 -0.21 -0.18 -0.15 -0.17 -0.18 -0.15 -0.17 -0.16 -0.19 -0.17 -0.174
Sloan Accruals snapshot only -0.195
Cash Flow Adequacy snapshot only 2.374
Earnings Quality Score snapshot only 0.750
Dividends & Buybacks
Metric Trend Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
Dividend Yield — — — — — — — — — — — — — — — — — 0.75%
Dividend/Share $0.00 $0.05 $0.05 $0.11 $0.10 $0.05 $0.05 $0.06 $0.06 $0.13 $0.13 $0.15 $0.16 $0.17 $0.17 $0.18 $0.17 $0.09
Payout Ratio 1.7% 54.5% 25.7% 39.7% 56.1% 16.5% 16.0% 12.5% 10.2% 17.5% 14.2% 16.1% 24.4% 32.6% 38.1% 50.8% 26.9% 26.91%
FCF Payout Ratio 0.9% 18.0% 9.1% 11.9% 7.9% 3.2% 3.6% 4.4% 4.9% 13.0% 10.7% 11.0% 17.1% 15.9% 12.8% 13.2% 10.7% 10.71%
Total Payout Ratio 1.7% 54.5% 25.7% 39.7% 56.1% 16.5% 16.0% 12.5% 10.2% 18.6% 15.1% 18.4% 28.0% 35.5% 41.5% 1.0% 99.4% 99.44%
Div. Increase Streak 0 0 0 0 1 1 1 0 0 1 1 0 0 1 1 1 1 0
Chowder Number — — — — — — — — — — — — — — — — — —
Buyback Yield — — — — — — — — — — — — — — — — — —
Net Buyback Yield — — — — — — — — — — — — — — — — — —
Total Shareholder Return — — — — — — — — — — — — — — — — — —
DuPont Factors
Metric Trend Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
Tax Burden (NI/EBT) 0.73 0.69 0.71 0.72 0.64 0.70 0.58 0.63 0.65 0.67 0.75 0.69 0.52 0.47 0.39 0.36 0.57 0.571
Interest Burden (EBT/EBIT) 0.88 0.77 0.80 0.86 0.83 1.11 1.44 1.60 1.39 1.46 1.34 1.35 1.74 1.28 0.99 0.69 0.53 0.527
EBIT Margin 0.05 0.03 0.04 0.04 0.03 0.03 0.03 0.04 0.05 0.05 0.06 0.07 0.05 0.06 0.06 0.06 0.09 0.089
Asset Turnover 0.53 0.97 1.53 1.69 2.13 2.04 2.18 2.05 2.17 2.19 2.20 1.82 1.81 1.86 1.85 2.33 2.26 2.257
Equity Multiplier 2.02 2.42 2.31 2.87 2.42 2.59 2.43 2.61 2.56 2.46 2.36 2.44 2.53 2.47 2.74 2.45 2.65 2.648
Per Share
Metric Trend Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
EPS (Diluted TTM) $0.08 $0.09 $0.20 $0.27 $0.19 $0.33 $0.34 $0.52 $0.63 $0.76 $0.94 $0.90 $0.67 $0.53 $0.46 $0.36 $0.63 $0.63
Book Value/Share $2.29 $2.20 $2.31 $2.34 $2.34 $2.53 $2.67 $2.87 $3.04 $3.26 $3.59 $3.72 $3.63 $3.64 $4.18 $4.12 $4.17 $4.28
Tangible Book/Share $-0.67 $-1.36 $-1.15 $-1.06 $-0.89 $-0.73 $-0.52 $-0.17 $0.01 $-0.01 $0.01 $-0.77 $-1.04 $-1.17 $-2.28 $-1.00 $-1.36 $-1.36
Revenue/Share $2.46 $5.17 $8.17 $11.32 $11.74 $12.47 $13.12 $13.79 $14.89 $15.55 $16.24 $14.64 $15.27 $15.90 $19.67 $22.44 $23.70 $10.31
FCF/Share $0.16 $0.28 $0.56 $0.89 $1.32 $1.70 $1.52 $1.45 $1.32 $1.03 $1.25 $1.32 $0.96 $1.09 $1.35 $1.39 $1.59 $0.62
OCF/Share $0.23 $0.43 $0.81 $1.23 $1.67 $2.06 $1.93 $1.91 $1.90 $1.79 $2.24 $2.38 $1.96 $2.01 $2.16 $2.15 $2.46 $1.03
Cash/Share $0.22 $0.18 $0.18 $0.10 $0.30 $0.57 $0.47 $0.30 $0.69 $0.38 $0.33 $0.45 $0.23 $0.16 $0.31 $0.17 $0.26 $0.27
EBITDA/Share $0.33 $0.59 $0.99 $1.40 $1.44 $1.62 $1.73 $1.83 $2.07 $2.18 $2.34 $2.32 $2.61 $2.75 $3.57 $4.03 $4.33 $4.33
Debt/Share $1.22 $1.84 $1.62 $1.47 $2.56 $2.58 $2.55 $2.59 $2.64 $2.61 $2.78 $3.74 $4.01 $4.12 $3.47 $3.80 $4.60 $4.60
Net Debt/Share $1.00 $1.66 $1.45 $1.37 $2.26 $2.01 $2.08 $2.28 $1.96 $2.23 $2.45 $3.29 $3.78 $3.96 $3.16 $3.63 $4.34 $4.34
Academic Models
Metric Trend Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — —
Piotroski F-Score 4 4 4 4 5 5 7 7 8 8 8 6 4 4 5 5 6 6
Beneish M-Score — — — — -2.85 -3.58 -3.40 -3.39 -3.11 -3.01 -3.10 -3.15 -2.59 -2.98 -1.63 -1.78 -2.49 -2.493
Ohlson O-Score snapshot only -6.688
Net-Net WC snapshot only $-4.65
EVA snapshot only $42216358.73
Credit
Metric Trend Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
Credit Rating snapshot only BBB+
Credit Score 62.90 62.90 72.50 67.50 62.25 62.25 61.25 63.75 67.50 64.35 64.35 64.35 54.00 54.00 62.10 65.25 63.75 63.750
Credit Grade snapshot only 8
Credit Trend snapshot only 9.750
Implied Spread (bps) snapshot only 225.000

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms